447 related articles for article (PubMed ID: 29525688)
1. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
Li Y; Ruan X; Wang H; Li X; Cai G; Du J; Wang L; Zhao Y; Mueck AO
Fertil Steril; 2018 Apr; 109(4):720-727. PubMed ID: 29525688
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome.
Mejia RB; Summers KM; Kresowik JD; Van Voorhis BJ
Fertil Steril; 2019 Mar; 111(3):571-578.e1. PubMed ID: 30683591
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization.
Sterling L; Liu J; Okun N; Sakhuja A; Sierra S; Greenblatt E
Fertil Steril; 2016 Mar; 105(3):791-797.e2. PubMed ID: 26654973
[TBL] [Abstract][Full Text] [Related]
5. Obstetric complications after frozen versus fresh embryo transfer in women with polycystic ovary syndrome: results from a randomized trial.
Zhang B; Wei D; Legro RS; Shi Y; Li J; Zhang L; Hong Y; Sun G; Zhang T; Li W; Chen ZJ
Fertil Steril; 2018 Feb; 109(2):324-329. PubMed ID: 29338857
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?
Chen Z; Tan J; Wang H; Zheng B; Liu J; Hao G; Guo Z; Sun Z; Yu Q
Front Endocrinol (Lausanne); 2022; 13():813188. PubMed ID: 35282449
[TBL] [Abstract][Full Text] [Related]
7. Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS).
Ashrafi M; Sheikhan F; Arabipoor A; Hosseini R; Nourbakhsh F; Zolfaghari Z
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():195-9. PubMed ID: 25150960
[TBL] [Abstract][Full Text] [Related]
8. Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype.
de Wilde MA; Lamain-de Ruiter M; Veltman-Verhulst SM; Kwee A; Laven JS; Lambalk CB; Eijkemans MJC; Franx A; Fauser BCJM; Koster MPH
Fertil Steril; 2017 Aug; 108(2):333-340. PubMed ID: 28778282
[TBL] [Abstract][Full Text] [Related]
9. Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome.
Ye H; Tian H; He W; Lyu Q; Kuang Y; Chen Q; Sun L
Reprod Biol Endocrinol; 2018 May; 16(1):53. PubMed ID: 29807533
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome.
Neveu N; Granger L; St-Michel P; Lavoie HB
Fertil Steril; 2007 Jan; 87(1):113-20. PubMed ID: 17081535
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial evaluating the effect of ethinyl estradiol during clomiphene citrate cycles among women with polycystic ovary syndrome.
Moini A; Ahmadi F; Jahangiri N; Ahmadi J; Akhoond MR
Int J Gynaecol Obstet; 2015 Nov; 131(2):129-32. PubMed ID: 26391671
[TBL] [Abstract][Full Text] [Related]
12. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
Chen X; Gissler M; Lavebratt C
Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
[TBL] [Abstract][Full Text] [Related]
13. Obstetric and perinatal outcomes of singleton pregnancies conceived via assisted reproductive technology complicated by gestational diabetes mellitus: a prospective cohort study.
Kouhkan A; Khamseh ME; Pirjani R; Moini A; Arabipoor A; Maroufizadeh S; Hosseini R; Baradaran HR
BMC Pregnancy Childbirth; 2018 Dec; 18(1):495. PubMed ID: 30547777
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.
Seaman HE; de Vries CS; Farmer RD
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):427-36. PubMed ID: 15269926
[TBL] [Abstract][Full Text] [Related]
15. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
[TBL] [Abstract][Full Text] [Related]
16. A retrospective cohort study of obstetric complications and birth outcomes in women with polycystic ovarian syndrome.
Liu Q; Wang J; Xu Q; Kong L; Wang J
J Obstet Gynaecol; 2022 May; 42(4):574-579. PubMed ID: 34392796
[TBL] [Abstract][Full Text] [Related]
17. Benefit of Delayed Fertility Therapy With Preconception Weight Loss Over Immediate Therapy in Obese Women With PCOS.
Legro RS; Dodson WC; Kunselman AR; Stetter CM; Kris-Etherton PM; Williams NI; Gnatuk CL; Estes SJ; Allison KC; Sarwer DB; Diamond MP; Schlaff WD; Casson PR; Christman GM; Barnhart KT; Bates GW; Usadi R; Lucidi S; Baker V; Zhang H; Eisenberg E; Coutifaris C; Dokras A
J Clin Endocrinol Metab; 2016 Jul; 101(7):2658-66. PubMed ID: 27172435
[TBL] [Abstract][Full Text] [Related]
18. [Effect of hyperandrogenism on obstetric complications of singleton pregnancy from in vitro fertilization in women with polycystic ovary syndrome].
Wei DM; Zhang ZZ; Wang Z; Li P; Wang JF; Liu YJ; Zhang JT; Shi YH
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):18-22. PubMed ID: 29374881
[No Abstract] [Full Text] [Related]
19. Highly elevated level of antimüllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction.
Kaing A; Jaswa EA; Diamond MP; Legro RS; Cedars MI; Huddleston HG
Fertil Steril; 2021 Feb; 115(2):438-446. PubMed ID: 32883514
[TBL] [Abstract][Full Text] [Related]
20. Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents.
Jungheim ES; Odibo AO
Fertil Steril; 2010 Dec; 94(7):2659-64. PubMed ID: 20451181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
